Akari Therapeutics, Plc (NASDAQ:AKTX) gained 56.35% in yesterday’s day, going up from its prior closing price of $5.59 to $8.74 The stock price went upward in 7 of the last 10 days and has generated 143.45% during the last two weeks. The upbeat movement of both volume and price during the recent session is interpreted as a good sign, and, overall 10.69 million more shares exchanged hands compared with prior day. In total, 10.78 M shares exchanged hands for about $94.18 million.
Inside AKTX’s Recent Trend
Akari Therapeutics, Plc (AKTX) has broken the very wide and horizontal trend up. Breaks like this are often followed by swift and strong movements, and any correction down to the breakline at approximately. $6.50 is considered to be a second chance to hit a potential runner. It is, however, important that volume does follow the price as false breaks may appear and it may move back into the horizontal trend. Based on the rectangle-formation theory the stock is predicted to reach $9.55 sometime over the course of a quarter.
Akari Therapeutics, Plc Technical Signals
AKTX has witnessed its long term and short term MA triggering a buy signal. Many traders watch for short-term averages to cross above long-term averages to signal the beginning of an uptrend. Upon corrections, the price will meet support from the averages between $6.20 and $4.34. A break down through these support points will trigger sell signals. Its pivot point low generated buy signal on Friday September 15, 2017, which calls for additional surge until the stock forms a new pivot point high. There was increase in both volume and price. This is usually interpreted as a good sign as traders widely believe rising stock should see increasing volume.
Akari Therapeutics, Plc (NASDAQ:AKTX) Support And Resistance Levels
There is no support from accumulated volume below today’s level and given the right condition the stock may perform very badly in the next couple of days. It seems to be blessed by the accumulated volume as it meets no resistance above current level and favorable trading conditions will help the stock to show strong performance in the coming days.
Akari Therapeutics, Plc (AKTX) Risk Assessment
A volatility based measure Bollinger Bands suggests this stock poses high risk. In the most recent session, the stock price hovered around $5.76 between high and low, or 93.05%. The average volatility for the past week stood at 30.37%.
The stock is extremely overbought on RSI14 (83). Normally this will pose a good selling opportunity, but since the stock has broken the trend up the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.